08:25 EDT Lantern Pharma (LTRN) trading halted, news pending
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LTRN:
- Lantern Pharma announces completion of Type C meeting with FDA
- Lantern Pharma Reports Q2 2025 Earnings and Strategic Progress
- Lantern Pharma completes targeted enrollment for HARMONIC trial
- Lantern Pharma Appoints Dr. Schalop to Board
- Lantern reports complete response in pretreated Lymphoma patient with LP-284